PeptideStack
5.2kquestions
20kanswers
220users

Is HJ worth the price difference against Sangon Biotech (Shanghai) on measured results?

Asked 9 Mar 2025Modified 13 months agoViewed 14k times
10

Concretely: HJ · Sangon Biotech (Shanghai).

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

Is there a defensible reason to prefer one, or is this a coin flip?

vendor-comparison
vendor-comparison

Side-by-side comparison of suppliers on measurable axes - independently confirmed purity and content, lead time, cold-chain handling,…

388 questions
cost-analysis
cost-analysis

Cost arithmetic done honestly: cost per milligram after dead-space loss, list versus net price, comparing a multi-dose vial to a fixed-dose pen,…

260 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
shareeditfollowflag
MT
askedmarcus_thorbjorn9.4k169 Mar 2025
Same question before my first order, and the small-order-then-test route worked. – marta_okonkwo 4 months ago
2Do you have a certificate in front of you, or are you asking before requesting one? – tenth_of_a_unit 6 months ago
add a comment

5 Answers

Accepted answer first, then by votes
87

Accepted answer

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Compare content, not purity. Purity clusters and content does not.

shareimprove this answerflag
PH
answered · acceptedpetra_hovland35k3831 Mar 2025
6Worth adding that legal position and enforcement posture are different things. – t_oyelaran 31 days ago
7I would add a line about writing the accept threshold down first. It is the step everyone skips. – Dr_Colm_Fitzhenry 3 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
33

This is the question where methodology matters more than the conclusion.

Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

Name the laboratory and the dates or the comparison cannot be reproduced.

shareimprove this answerflag
ET
answeredellis_thorne17k1711 Apr 2025
5Is there a sensible order size where independent testing stops being a large surcharge? – mateo_iglesias 8 months ago
add a comment
24

Ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

One laboratory, one method, one submission. Otherwise it is not a comparison.

edited 12 Jul 2025 by w_okoye — updated for the 2026 guidance change

shareimprove this answerflag
WO
answeredw_okoye43k1377 Jul 2025
19

A single member running three suppliers on one method is worth more than thirty members running one supplier each.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Price per milligram of measured peptide, not per milligram of label claim.

shareimprove this answerflag
PH
answeredpetra_hovland35k3820 Mar 2025
16

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Use a fixed documentation checklist rather than an impression.

edited 27 May 2025 by meniscus_film — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
MF
answeredmeniscus_film32k2714 May 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.